"Protagonist Therapeutics Announces Initial Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera"
about Protagonist Therapeutics,..
Notified: 16:31 EDT at $7.73
"Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium®"
about Sesen Bio, Inc.
Notified: 16:42 EDT at $0.80
"Nielsen Holdings Files Initial Form 10 Registration Statement for Proposed Spin-Off of Global Connect Business"
about Nielsen N.V. Ordinary Sha..
Notified: 16:42 EDT at $13.68
"U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study"
about Pluristem Therapeutics, I..
Notified: 06:00 EDT at $8.69
"RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S."
about Redhill Biopharma Ltd.
Notified: 07:01 EDT at $6.89
"Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to Develop Novel Oligonucleotide Platform for the ..."
about Fortress Biotech, Inc.
Notified: 07:30 EDT at $2.75
"Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers"
about Avalon Holdings Corp.
Notified: 09:00 EDT at $1.92
"OPKO Health's BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents"
about Opko Health, Inc.
Notified: 09:01 EDT at $2.08
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.